Kura Oncology (KURA) Enterprise Value (2010 - 2026)
Kura Oncology (KURA) reported Enterprise Value of -$580.8 million for Q1 2026, up 11.75% year-over-year from -$519.7 million in Q1 2025, and up 12.95% on a QoQ basis from -$667.2 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Enterprise Value data on file, last reported at -$580.8 million in Q1 2026.
- Quarterly Enterprise Value rose 11.75% year-over-year to -$580.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$580.8 million (up 11.75% YoY) and the FY2025 annual result came in at -$667.2 million, up 8.27% from the prior year.
- Enterprise Value climbed to -$580.8 million in Q1 2026 per KURA's latest filing, from -$667.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$405.9 million in Q1 2023 and bottomed at -$727.4 million in Q4 2024.
- The 5-year median for Enterprise Value is -$480.1 million (2022), against an average of -$520.2 million.
- The widest annual swing landed in 2022, when Enterprise Value gained 21.28%; it then plunged 71.57% in 2024.
- Tracing KURA's Enterprise Value over 5 years: stood at -$438.0 million in 2022, then climbed by 3.2% to -$424.0 million in 2023, then sank by 71.57% to -$727.4 million in 2024, then climbed by 8.27% to -$667.2 million in 2025, then increased by 12.95% to -$580.8 million in 2026.
- Per Business Quant, the three latest KURA Enterprise Value figures stand at -$580.8 million (Q1 2026), -$667.2 million (Q4 2025), and -$549.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -580.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -580.82 Mn |
| Dec 31, 2025 | -667.24 Mn |
| Sep 30, 2025 | -549.67 Mn |
| Jun 30, 2025 | -630.73 Mn |
| Mar 31, 2025 | -658.19 Mn |
| Dec 31, 2024 | -727.40 Mn |
| Sep 30, 2024 | -455.30 Mn |
| Jun 30, 2024 | -491.52 Mn |
| Mar 31, 2024 | -527.12 Mn |
| Dec 31, 2023 | -423.96 Mn |
| Sep 30, 2023 | -452.59 Mn |
| Jun 30, 2023 | -476.98 Mn |
| Mar 31, 2023 | -405.90 Mn |
| Dec 31, 2022 | -437.99 Mn |
| Sep 30, 2022 | -427.78 Mn |
| Jun 30, 2022 | -450.26 Mn |
| Mar 31, 2022 | -480.08 Mn |
| Dec 31, 2021 | -517.96 Mn |
| Sep 30, 2021 | -543.45 Mn |
| Jun 30, 2021 | -567.49 Mn |
| Mar 31, 2021 | -603.87 Mn |
| Dec 31, 2020 | -633.32 Mn |
| Sep 30, 2020 | -325.41 Mn |
| Jun 30, 2020 | -338.87 Mn |
| Mar 31, 2020 | -216.94 Mn |
| Dec 31, 2019 | -236.89 Mn |
| Sep 30, 2019 | -250.13 Mn |
| Jun 30, 2019 | -261.41 Mn |
| Mar 31, 2019 | -165.53 Mn |
| Dec 31, 2018 | -178.99 Mn |
| Sep 30, 2018 | -187.42 Mn |
| Jun 30, 2018 | -125.89 Mn |
| Mar 31, 2018 | -138.20 Mn |
| Dec 31, 2017 | -93.15 Mn |
| Sep 30, 2017 | -100.81 Mn |
| Jun 30, 2017 | -53.24 Mn |
| Mar 31, 2017 | -59.15 Mn |
| Dec 31, 2016 | -67.79 Mn |
| Sep 30, 2016 | -74.57 Mn |
| Jun 30, 2016 | -80.09 Mn |
| Mar 31, 2016 | -74.25 Mn |
| Dec 31, 2015 | -85.75 Mn |
| Sep 30, 2015 | -41.23 Mn |
| Jun 30, 2015 | -45.93 Mn |
| Mar 31, 2015 | -53.57 Mn |
| Dec 31, 2014 | -1.12 Mn |
| Sep 30, 2014 | -82,000.00 |
| Jun 30, 2014 | -4,918.00 |
| Mar 31, 2014 | -6,168.00 |
| Dec 31, 2013 | -6,568.00 |
| Sep 30, 2013 | -10,580.00 |
| Jun 30, 2013 | -18,705.00 |
| Mar 31, 2013 | -2,901.00 |
| Dec 31, 2012 | -4,802.00 |
| Sep 30, 2012 | -5,586.00 |
| Jun 30, 2012 | -9,481.00 |
| Mar 31, 2012 | -23,743.00 |
| Dec 31, 2011 | -4,220.00 |
| Sep 30, 2011 | -6,155.00 |
| Jun 30, 2011 | -9,255.00 |
| Mar 31, 2011 | -4,220.00 |
| Dec 31, 2010 | -26,898.00 |
| Sep 30, 2010 | -2,254.00 |